These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. DNA Repair Function Scores for 2172 Variants in the BRCA1 Amino-Terminus. Diabate M; Islam MM; Nagy G; Banerjee T; Dhar S; Smith N; Adamovich AI; Starita LM; Parvin JD bioRxiv; 2023 Apr; ():. PubMed ID: 37090572 [TBL] [Abstract][Full Text] [Related]
13. Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel. Parsons MT; de la Hoya M; Richardson ME; Tudini E; Anderson M; Berkofsky-Fessler W; Caputo SM; Chan RC; Cline MS; Feng BJ; Fortuno C; Gomez-Garcia E; Hadler J; Hiraki S; Holdren M; Houdayer C; Hruska K; James P; Karam R; Leong HS; Martins A; Mensenkamp AR; Monteiro AN; Nathan V; O'Connor R; Pedersen IS; Pesaran T; Radice P; Schmidt G; Southey M; Tavtigian S; Thompson BA; Toland AE; Turnbull C; Vogel MJ; Weyandt J; Wiggins GAR; Zec L; Couch FJ; Walker LC; Vreeswijk MPG; Goldgar DE; Spurdle AB Am J Hum Genet; 2024 Sep; 111(9):2044-2058. PubMed ID: 39142283 [TBL] [Abstract][Full Text] [Related]
14. A Validated Functional Analysis of Partner and Localizer of BRCA2 Missense Variants for Use in Clinical Variant Interpretation. Brnich SE; Arteaga EC; Wang Y; Tan X; Berg JS J Mol Diagn; 2021 Jul; 23(7):847-864. PubMed ID: 33964450 [TBL] [Abstract][Full Text] [Related]
15. Accurate classification of BRCA1 variants with saturation genome editing. Findlay GM; Daza RM; Martin B; Zhang MD; Leith AP; Gasperini M; Janizek JD; Huang X; Starita LM; Shendure J Nature; 2018 Oct; 562(7726):217-222. PubMed ID: 30209399 [TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231 [TBL] [Abstract][Full Text] [Related]
17. Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction. Caleca L; Catucci I; Figlioli G; De Cecco L; Pesaran T; Ward M; Volorio S; Falanga A; Marchetti M; Iascone M; Tondini C; Zambelli A; Azzollini J; Manoukian S; Radice P; Peterlongo P Front Oncol; 2018; 8():480. PubMed ID: 30410870 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches. Guidugli L; Shimelis H; Masica DL; Pankratz VS; Lipton GB; Singh N; Hu C; Monteiro ANA; Lindor NM; Goldgar DE; Karchin R; Iversen ES; Couch FJ Am J Hum Genet; 2018 Feb; 102(2):233-248. PubMed ID: 29394989 [TBL] [Abstract][Full Text] [Related]
19. Specifications of the ACMG/AMP Variant Classification Guidelines for Germline Hatton JN; Frone MN; Cox HC; Crowley SB; Hiraki S; Yokoyama NN; Abul-Husn NS; Amatruda JF; Anderson MJ; Bofill-De Ros X; Carr AG; Chao EC; Chen KS; Gu S; Higgs C; Machado J; Ritter D; Schultz KA; Soper ER; Wu MK; Mester JL; Kim J; Foulkes WD; Witkowski L; Stewart DR Hum Mutat; 2023; 2023():. PubMed ID: 38084291 [TBL] [Abstract][Full Text] [Related]
20. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines. So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]